2023
August
22,
2023
|
13:59 PM
Europe/Amsterdam
Berlin, August 22, 2023 – Bayer today announced Juergen Eckhardt MD, MBA as the new Head of Business Development & Licensing / Open Innovation (BDL/OI) of its Pharmaceuticals Division effective September 1, 2023. He will join the Pharmaceuticals Exec...
Read more
August
21,
2023
|
16:44 PM
Europe/Amsterdam
Leverkusen, August 21, 2023 – The Supervisory Board of Bayer AG has unanimously appointed Heike Prinz to Bayer’s Board of Management effective September 1, 2023. She will become the company’s Chief Talent Officer and Labor Director. This follows the ...
Read more
February
08,
2023
|
17:14 PM
Europe/Amsterdam
Leverkusen, February 8, 2023 – The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimo...
Read more
January
24,
2023
|
13:59 PM
Europe/Amsterdam
Jeffrey Hatfield becomes Chairman of the Board of Directors at Vividion Therapeutics
Read more
2022
September
01,
2022
|
16:00 PM
Europe/Amsterdam
Succeeds Fei-Fei Li, who stepped down at the end of August
Read more
April
21,
2022
|
15:00 PM
Europe/Amsterdam
Berlin, April 21, 2022 - Bayer today announced Tara Frenkl, MD, MPH as the new Head of Oncology Development at its Oncology Strategic Business Unit, effective April 25, 2022. She will report to Christine Roth, Head of the Oncology Strategic Business ...
Read more
March
03,
2022
|
09:00 AM
Europe/Amsterdam
Kelly Gast appointed as new Chief Financial Officer, effective April 1, 2022 / Frank Terhorst to lead new team combining Strategy with Sustainability & Public Affairs, effective March 1, 2022
Read more
February
03,
2022
|
17:30 PM
Europe/Amsterdam
Berlin, February 3, 2022 - Bayer today announced Christine Roth as the new Head of the Oncology Strategic Business Unit at its Pharmaceuticals Division, effective March 1, 2022. She will report to Stefan Oelrich, Member of the Board of Management, Ba...
Read more
February
02,
2022
|
11:00 AM
Europe/Amsterdam
Basel, Switzerland, February 2, 2022 - Today Bayer announced Dr. Ricardo Salazar Hernández as the new Global Medical Affairs function with responsibilities over medical insights, claims and evidence strategies and generation, and health care professi...
Read more
2021
November
09,
2021
|
07:29 AM
Europe/Amsterdam
Liam Condon to leave the company on December 31, 2021
Read more
November
04,
2021
|
13:00 PM
Europe/Amsterdam
Berlin, Germany, November 4, 2021 - Bayer today announced Christoph Koenen as the new Global Head of Clinical Development and Operations within Research and Development at its Pharmaceuticals Division, effective January 1, 2022."We are very pleased t...
Read more
July
26,
2021
|
08:30 AM
Europe/Amsterdam
Berlin, Germany, July 26, 2021 - Bayer today announced Prof. Dr. Dominik Ruettinger as the new Head of Research and Early Development for Oncology at its Pharmaceuticals Division, effective October 1, 2021."We are pleased to welcome Dominik Ruettinge...
Read more
May
18,
2021
|
14:30 PM
Europe/Amsterdam
Monheim, May 18, 2021 - Bayer today announced that Brett Begemann, Chief Operating Officer, Crop Science, will retire from his role after 38 years with the company.Rodrigo Santos, currently Head of Crop Science Commercial Operations, Latin America, w...
Read more
March
12,
2021
|
10:00 AM
Europe/Amsterdam
Fei-Fei Li and Alberto Weisser proposed as successors to Johanna Faber and Prof. Dr. Wolfgang Plischke / Supervisory Board compensation to be adjusted
Read more
February
22,
2021
|
09:00 AM
Europe/Amsterdam
Leverkusen, February 22, 2021 - Bayer is further strengthening its efforts to foster a more inclusive and diverse workforce and culture. By 2025, the company aspires to establish a 50/50 gender balance as an average across all combined management lev...
Read more
January
12,
2021
|
17:00 PM
Europe/Amsterdam
Research Triangle Park, N.C. - January 12, 2021 - Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned subsidiary of Bayer AG, today announced that Katherine High, MD, has joi...
Read more
January
11,
2021
|
13:01 PM
Europe/Amsterdam
Leverkusen, January 11, 2021 - The Supervisory Board of Bayer AG announced the appointment of Sarena Lin (50) to the company’s Board of Management as of February 1, 2021. Lin will become the company’s Chief Transformation and Talent Officer. She will...
Read more
2020
October
27,
2020
|
14:00 PM
Europe/Amsterdam
Berlin, October 27, 2020 - Bayer today announced Dr. Christian Rommel as the new Head of Research and Development at its Pharmaceuticals Division, effective February 1, 2021. He will report to Stefan Oelrich, Member of the Board of Management, Bayer ...
Read more
September
10,
2020
|
21:30 PM
Europe/Amsterdam
Company also announces progress in Roundup™ settlements
Read more
August
18,
2020
|
14:30 PM
Europe/Amsterdam
Monheim, Germany, August 18, 2020 - Bayer announced today that Sara Boettiger, Ph.D. will lead the global Crop Science Public Affairs, Science and Sustainability organization effective September 1, 2020. As a member of the Executive Leadership team f...
Read more
February
26,
2020
|
09:50 AM
Europe/Amsterdam
Werner Wenning to retire after over 50 years with Bayer / Horst Baier proposed for election as new shareholder representative
Read more
2019
October
01,
2019
|
15:00 PM
Europe/Amsterdam
International expert in the area of nutrition and agriculture / Cousin succeeds Thomas Ebeling, who stepped down at the end of September
Read more
September
10,
2019
|
15:00 PM
Europe/Amsterdam
Leverkusen, September 10, 2019 - The Supervisory Board of Bayer AG on Tuesday decided to reduce the size of the company’s Board of Management from seven to five members effective January 1, 2020. Dr. Hartmut Klusik (63) and Kemal Malik (56) will leav...
Read more
2018
September
13,
2018
|
12:00 PM
Europe/Amsterdam
Dieter Weinand leaving the company as of November 1, 2018 / Contract extensions for Board of Management members Liam Condon and Dr. Hartmut Klusik
Read more
2017
November
15,
2017
|
08:30 AM
Europe/Amsterdam
Erica Mann to leave Bayer effective March 31, 2018
Read more
September
12,
2017
|
12:00 PM
Europe/Amsterdam
Leverkusen, September 12, 2017 - The Supervisory Board of Bayer AG has appointed Wolfgang Nickl (48) to the Board of Management of Bayer AG effective April 26, 2018. He is to succeed Johannes Dietsch (55) as the company’s Chief Financial Officer on J...
Read more
